DCGI allows Biophore India to manufacture coronavirus drug Favipiravir API
Hyderabad: Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture ...
Read moreDetails
Hyderabad: Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture ...
Read moreDetailsNew Delhi: Biocon said Wednesday that its medical device to treat COVID-19 patient has received approval from the Drugs Controller ...
Read moreDetails
India is being shown in such a poor light that it does not stand comparison on the question of a...
Read moreDetails
Finally, the much-awaited biggest diplomatic breakthrough in the US-Israel war with Iran has been made with the US and Iran...
Read moreDetails
Kyiv saw a unique phenomenon recently when thousands of readers gathered at a literary festival defying air raids only to...
Read moreDetails
Aakar Patel A ‘New India’ has come upon us at such a rapid pace that it is important to...
Read moreDetails